Ginkgo Bioworks is set to go public by merging with Soaring Eagle Acquisition Corp., a SPAC.
The shares acquired by investors at the pre-IPO stage will be converted into shares of the public company (DNA ticker) in a certain ratio. We are awaiting information on the conversion rate from Ginkgo Bioworks. This means that for a while Ginkgo stock price in your personal account will not match the DNA stock price.
In October 2020, when we offered investments in Ginkgo Bioworks pre-IPO stocks, the stock was worth $138.6 at a total valuation of $4.5 billion. Today, the company will go public with a valuation of $15 billion.
Stay tuned for any updates!